PDS Biotechnology Corp Annual Operating Income (Loss) in USD from 2013 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
PDS Biotechnology Corp quarterly/annual Operating Income (Loss) history and growth rate from 2013 to 2023.
  • PDS Biotechnology Corp Operating Income (Loss) for the quarter ending September 30, 2024 was -$10.2M, a 3.24% increase year-over-year.
  • PDS Biotechnology Corp Operating Income (Loss) for the twelve months ending September 30, 2024 was -$39.4M, a 23.5% increase year-over-year.
  • PDS Biotechnology Corp annual Operating Income (Loss) for 2023 was -$43M, a 3.29% decline from 2022.
  • PDS Biotechnology Corp annual Operating Income (Loss) for 2022 was -$41.7M, a 94.4% decline from 2021.
  • PDS Biotechnology Corp annual Operating Income (Loss) for 2021 was -$21.4M, a 43.9% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$43M -$1.37M -3.29% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-28
2022 -$41.7M -$20.2M -94.4% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 -$21.4M -$6.54M -43.9% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-28
2020 -$14.9M +$6.13M +29.2% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
2019 -$21M -$17.4M -477% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-18
2018 -$3.65M +$48.3M +93% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-27
2017 -$52M -$12.5M -31.5% Jan 1, 2017 Dec 31, 2017 10-K 2019-02-21
2016 -$39.5M -$13M -49.1% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-01
2015 -$26.5M -$13.3M -101% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-01
2014 -$13.2M -$6.71M -103% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-02
2013 -$6.49M Jan 1, 2013 Dec 31, 2013 10-K 2016-03-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.